These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33724543)

  • 41. Quantitative evaluation of the relaxivity effects of iodine on GD-DTPA enhanced MR arthrography.
    Ganguly A; Gold GE; Butts Pauly K; Mayer D; Moseley MM; Pelc NJ; Fahrig R
    J Magn Reson Imaging; 2007 Jun; 25(6):1219-25. PubMed ID: 17520728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
    Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
    Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S; Ruloff R; Tóth E; Merbach AE
    Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compact Micellization: A Strategy for Ultrahigh T1 Magnetic Resonance Contrast with Gadolinium-Based Nanocrystals.
    Johnson NJ; He S; Nguyen Huu VA; Almutairi A
    ACS Nano; 2016 Sep; 10(9):8299-307. PubMed ID: 27588579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.
    Tóth E; Bolskar RD; Borel A; González G; Helm L; Merbach AE; Sitharaman B; Wilson LJ
    J Am Chem Soc; 2005 Jan; 127(2):799-805. PubMed ID: 15643906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
    Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA
    ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strategic reconstruction of macrophage-derived extracellular vesicles as a magnetic resonance imaging contrast agent.
    Rayamajhi S; Marasini R; Nguyen TDT; Plattner BL; Biller D; Aryal S
    Biomater Sci; 2020 May; 8(10):2887-2904. PubMed ID: 32300771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies.
    Mortezazadeh T; Gholibegloo E; Alam NR; Dehghani S; Haghgoo S; Ghanaati H; Khoobi M
    MAGMA; 2019 Aug; 32(4):487-500. PubMed ID: 30730021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Manipulating the surface coating of ultra-small Gd2O3 nanoparticles for improved T1-weighted MR imaging.
    Fang J; Chandrasekharan P; Liu XL; Yang Y; Lv YB; Yang CT; Ding J
    Biomaterials; 2014 Feb; 35(5):1636-42. PubMed ID: 24290697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 Tesla.
    Loai Y; Sakib N; Janik R; Foltz WD; Cheng HL
    Mol Imaging; 2012 Apr; 11(2):166-75. PubMed ID: 22469244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro T2 relaxivities of the Gd-based contrast agents (GBCAs) in human blood at 1.5 and 3 T.
    Shen Y; Goerner FL; Heverhagen JT; Snyder C; Hu D; Li X; Runge VM
    Acta Radiol; 2019 Jun; 60(6):694-701. PubMed ID: 30205704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gadolinium-based bimodal probes to enhance T1-Weighted magnetic resonance/optical imaging.
    Yang CT; Hattiholi A; Selvan ST; Yan SX; Fang WW; Chandrasekharan P; Koteswaraiah P; Herold CJ; Gulyás B; Aw SE; He T; Ng DCE; Padmanabhan P
    Acta Biomater; 2020 Jul; 110():15-36. PubMed ID: 32335310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Feasibility of using half-dose Gd-BOPTA for delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at the knee, compared with standard-dose Gd-DTPA.
    Rehnitz C; Do T; Klaan B; Burkholder I; Barié A; Wuennemann F; Kauczor HU; Weber MA
    J Magn Reson Imaging; 2020 Jan; 51(1):144-154. PubMed ID: 31141254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the Relaxivities of Macrocyclic Gadolinium-Based Contrast Agents in Human Plasma at 1.5, 3, and 7 T, and Blood at 3 T.
    Szomolanyi P; Rohrer M; Frenzel T; Noebauer-Huhmann IM; Jost G; Endrikat J; Trattnig S; Pietsch H
    Invest Radiol; 2019 Sep; 54(9):559-564. PubMed ID: 31124800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent.
    Lee HY; Lee SH; Xu C; Xie J; Lee JH; Wu B; Koh AL; Wang X; Sinclair R; Wang SX; Nishimura DG; Biswal S; Sun S; Cho SH; Chen X
    Nanotechnology; 2008 Apr; 19(16):165101. PubMed ID: 21394237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T.
    Reichenbach JR; Hackländer T; Harth T; Hofer M; Rassek M; Mödder U
    Eur Radiol; 1997; 7(2):264-74. PubMed ID: 9038129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.